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Spasticite´ (III) / Revue d’E´pide´miologie et dee340injections into the lumbar paraspinal muscles and we review the relevant
literature.
Case report.– A 27-year-old patient, with PKAN heredodegenerative dystonia,
has truncal dystonia symptomatology. Suddenly, she complained of low-back
pain evaluated at 10/10 on a verbal scale. Low-back pain is induced by repetitive
dystonic movements with upper limbs anterior elevation, spinal and hip
extension (opisthotonos). Radiographs showed a L3 bilateral spondylolysis not
shown in the previous radiographs. A classical corset immobilization isn’t
possible because of movement disorders. A first botulinum toxin injection is
performed (150 UI Botox1) in lumbar paraspinal muscles for pain relief.
Anterior head of deltoideus and gluteus maximus are also injected (for a total
dose of 400 UI Botox1 each session) to break the extension scheme. Four weeks
after injections, the pain is evaluated at 5/10 and movement disorders were less
frequent. Thanks to the adapted wheelchair and the posterior articulars
infiltration bilaterally (125 mg of hydrocortancyl), the patient is totally relieved.
Because of pain recurrence, toxin injections are effectively renewed each 3
months.
Discussion.– The increase of spondylolysis frequency is shown in CP patients
[1], one of the most frequent pathology with dystonia. The effectiveness of
botulinum toxin injections in spinal muscles to decrease contractions is hard to
prove but some articles agree with a decrease of disordered movements and pain
[2].
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We are reporting a case of a pneumothorax after BoNT-A injection.
A 58-year-old patient with right spastic proportional hemiplegia due to a
frontal meningioma surgery 36 years before required regular BoNT-A
injections. The muscles (subscapularis, anterior and posterior way, and
pectoralis major, two anterior injection sights) were injected with the help of
electrostimulation detection. During the 6th session, the subscapularis was
detected with difficulty. Two hours after the injection the patient presented
acute dyspnea. A pneumothorax was diagnosed and drained; the patient was
hospitalized in intensive care for 5 days. A relation between the injection and
the pneumothorax was then established. There were no after effects of this
episode.
This is the first described case of pneumothorax after BoNT-A injection. The
probable cause was the detection of the subscapularis and not the pectoralis
major who is superficial and easily spotted.
Similar cases were described during electromyographic exams of the muscles
teres major and pectoralis major but never for the subscapularis [1].
This case reminds of the necessity of a technical aid for the detection of the
muscles to be injected, as well as the risks taken while trying to detect thoracic
muscles.
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Introduction.– Botulinum toxin is an effective treatment for neurogenic or
idiopathic detrusor overactivity refractory to antimuscarinics. Nevertheless, it
can lead to locoregional and sometimes systemic complications like botulism-
like syndrome.
Observation.– A 24-year-old woman, quadriplegic Cervical 7 ASIA C, spastic
post-traumatic with detrusor overactivity at urodynamic assessment, was
effectively treated for a year by antimuscarinics and intradetrusor botulinum
toxin injections. Ten days after the last injection (Botox 300 UI), the patient
complained of generalized muscle weakness, an inability to manipulate the
steering wheel of her car and to transfer. The physical examination revealed an
increase in the deficit of the triceps (MRC scale 2 vs 3+ initially), and a loss of
67 and 72% of strength in the isometric assessment of right and left deltoids
respectively. The vital capacity was 2.07 L vs 2.36 L initially. The
neuromuscular jitter of the orbicularis oculi was impaired with 22.7% of
abnormal fibers and a mean jitter of 27.45 msec. Differential diagnoses were
excluded with anti-Musk and anti-Ach R negative, a spinal MRI showing the
absence of syringomyelia and compressive disc hernia, and the diagnosis of
botulism-like syndrome was made. The patient had a clinical and electro-
physiological follow-up, with a normalization of muscle power in a year and
slow improvement of neuromuscular jitter.
Discussion.– Several cases of generalized muscle weakness after intradetrusor
botulinum toxin injections have been described, with poorly understood
pathophysiological mechanisms. The interest of this observation is the one-year
follow-up with electrophysiological measures, muscle power evaluation and
occupational therapy evaluation of prehension. General complications of
botulinum toxin injections for detrusor overactivity require regular clinical and
electrophysiological monitoring. Patients should be informed of this potential
risk.
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Introduction.– The stiff-knee is a lack of shortening of the lower limb during
walking secondary to a defect of knee flexion during the swing phase. This is a
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of numerous studies in the literature. However, there is no consensus on the
diagnostic and therapeutic approach. We propose a diagnostic and therapeutic
decision algorithm developed from literature data and service experience of
MPR Toulouse University Hospital.
Material and method.– Some key clinical elements must be addressed, such
as the strength of the quadriceps, hip flexors and knee and calf muscle.
Spasticity of the quadriceps must be analyzed hip flexed and stretched
(rectus femoris). Offsetting a deficit of the psoas compensed with rectus
femoris as a hip flexor must be identified. Proprioceptive disorder potential
must be eliminated. Finally, the walking speed of the subject, the presence of
a dynamic equinus or a recurvatum knee must be integrated reasoning. The
clinical approach may be complemented by selective motor blocks or aquantified analysis of walking to clarify the pathophysiology of stiff-knee,
and guide treatment.
Results.– The therapeutic approach stems from the pathophysiological
mechanisms identified. Physical therapy is indicated, especially to perform
specific and intensive work on the walking pattern after botulinum toxin
injections. Injections of botulinum toxin are not systematic, and concern the
rectus femoris and/or vastis. A defect in distal shortening during swing phase
(equinus) or abnormalities in stance phase (equinus, knee recurvatum) must be
supported concurrently to maximize the improvement of walking pattern.
Conclusion.– The diagnostic and therapeutic decision algorithm will be submitted
to a committee of experts and prospectively evaluated to assess its validity.
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